• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION THE Q-TRAK SUBCUTANEOUS ELECTRODE; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION THE Q-TRAK SUBCUTANEOUS ELECTRODE; IMPLANTABLE LEAD Back to Search Results
Model Number 3010
Device Problems Signal Artifact/Noise (1036); Failure to Convert Rhythm (1540); Failure to Sense (1559); Low impedance (2285)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/24/2022
Event Type  Injury  
Event Description
It was reported that at a routine subcutaneous implantable defibrillator (s-icd) device replacement procedure for normal battery depletion, this device was implanted and with the automatic screening tool (ast), was programmed to the same sensing vector as the former device.However, when the physician performed an induction test, the shock was unable to convert the induced ventricular fibrillation (vf).Additionally, the real time internal device electrocardiogram (egm) displayed a flat line showing a lack of sensing.This was followed by high amplitude non-cardiac noisy signals.Because the patient was still in vf, the patient was externally shocked to convert their arrhythmia.The testing result for the induced shock revealed an impedance measurement of 1 ohm.The device was able to interrogated via telemetry and the physician noted an unspecified red alert message.Because there were no additional replacement devices available, the physician turned off the shock therapy and the patient was hospitalized.A few days later, the physician surgically explanted and replaced the entire s-icd system to resolve the event.No additional adverse effects were reported.The system is expected to be returned for analysis, but has not yet been received.
 
Event Description
It was reported that at a routine subcutaneous implantable defibrillator (s-icd) device replacement procedure for normal battery depletion, this device was implanted and with the automatic screening tool (ast), was programmed to the same sensing vector as the former device.However, when the physician performed an induction test, the shock was unable to convert the induced ventricular fibrillation (vf).Additionally, the real time internal device electrocardiogram (egm) displayed a flat line showing a lack of sensing.This was followed by high amplitude non-cardiac noisy signals.Because the patient was still in vf, the patient was externally shocked to convert their arrhythmia.The testing result for the induced shock revealed an impedance measurement of 1 ohm.The device was able to interrogated via telemetry and the physician noted an unspecified red alert message.Because there were no additional replacement devices available, the physician turned off the shock therapy and the patient was hospitalized.A few days later, the physician surgically explanted and replaced the entire s-icd system to resolve the event.No additional adverse effects were reported.The system was received for analysis.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, visual inspection revealed insulation damage near the electrode terminal end.The insulation abrasion went through to the high voltage lumen with additional damage to the sense a lumen.This type of damage is consistent with repeated stress over time.In this case, we believe the stress was the result of lead contact with the associated device case.The reported low shock impedance measurement, failure to convert rhythm and sense, and noisy signals allegations were likely the result of the electrode damage observed by the laboratory.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THE Q-TRAK SUBCUTANEOUS ELECTRODE
Type of Device
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key14806369
MDR Text Key294837814
Report Number2124215-2022-22779
Device Sequence Number1
Product Code LWS
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P110042/S000
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/30/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date10/01/2016
Device Model Number3010
Device Catalogue Number3010
Device Lot NumberA115438
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/10/2022
Initial Date FDA Received06/24/2022
Supplement Dates Manufacturer Received09/29/2022
Supplement Dates FDA Received10/01/2022
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age66 YR
Patient SexMale
-
-